lysophosphatidic acid has been researched along with Disease Exacerbation in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (27.59) | 29.6817 |
2010's | 16 (55.17) | 24.3611 |
2020's | 5 (17.24) | 2.80 |
Authors | Studies |
---|---|
Birnberg, A; Chakrabarti, A; Choy, DF; Grimbaldeston, MA; Li, Q; Neighbors, M; Olsson, J; Rosenberger, CM; Sandoval, W; Tew, GW; Verschueren, E; Wong, W; Yang, X | 1 |
Damirin, A; Li, A; Li, R; Sun, H; Wang, Y; Yan, Y; Yun, Q; Zhao, P | 1 |
Jia, G; Li, Q; Liu, J; Neighbors, M; Sandoval, W; Tew, GW; Wong, WR; Zhu, SJ | 1 |
Bai, H; Cao, G; Cui, R; Zhang, Z | 1 |
Cao, R; Jiang, H; Liu, S; Min, L; Ning, T; Wang, T; Wang, X; Xu, J; Zhang, Q; Zhang, S; Zhu, S | 1 |
Hegedüs, B; Rásó, E; Tímár, J | 1 |
Chen, CC; Chen, WM; Huang, YL; Jou, YC; Kanaho, Y; Lee, H; Lin, YC; Lu, KY; Ohbayashi, N; Shen, CH; Shen, TL | 1 |
Arsenault, BJ; Bossé, Y; Bouchareb, R; Boulanger, MC; Dahou, A; Hadji, F; Marette, A; Mathieu, P; Messadeq, Y; Mkannez, G; Nsaibia, MJ; Pibarot, P; Tastet, L | 1 |
Herrera, M; Losert, W; Parent, CA; Sato, M; Shou, K; Stuelten, CH; Vedham, V; Weiger, MC | 1 |
Bao, S; Day, R; Tan, C; Turk, J; Zhao, QD | 1 |
Cai, Q; Fan, Q; Xu, Y | 1 |
Hwang, YS; Lee, J; Lindholm, PF; Zhang, X | 1 |
Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS | 1 |
Fukushima, K; Fukushima, N; Honoki, K; Onishi, Y; Takahashi, K; Tsujiuchi, T; Yamasaki, E | 1 |
Fishman, DA; Pua, TL; Wang, FQ | 1 |
Lee, HY; Mills, GB; Panupinthu, N | 1 |
Biessen, EA; Bot, I; Bot, M; David, S; Helms, JB; Lopez-Vales, R; Saulnier-Blache, JS; van Berkel, TJ; van de Lest, CH | 1 |
Bekele, R; Brindley, DN; Capatos, D; Samadi, N; Sariahmetoglu, M; Venkatraman, G | 1 |
Bascands, JL; Buffin-Meyer, B; Klein, J; Miravete, M; Schanstra, JP | 1 |
Antonaci, S; Dituri, F; Giannelli, G; Lupo, L; Mazzocca, A; Quaranta, M | 1 |
Bastos, LG; Leve, F; Marcondes, TG; Morgado-Díaz, JA; Rabello, SV; Tanaka, MN | 1 |
Goldsmith, PK; Heger, CD; Kelly, K; Lake, R; Merino, M; Raffeld, M; Ward, Y; Yin, JJ | 1 |
Angeli, V; Fisher, EA; Liu, J; Llodrá, J; Randolph, GJ; Trogan, E | 1 |
Hirano, K; Koike, T; Satouchi, K; Tanaka, T; Tokumura, A; Tsutsui, H | 1 |
Gupta, GP; Massagué, J | 1 |
Bordet, JC; Boucharaba, A; Clézardin, P; Grès, S; Guglielmi, J; Peyruchaud, O; Saulnier-Blache, JS; Serre, CM | 1 |
Bordet, JC; Boucharaba, A; Clézardin, P; Guglielmi, J; Peyruchaud, O; Serre, CM | 1 |
Hashimoto, K; Kimura, T; Morishige, K; Ogata, S; Sakata, M; Sawada, K; Shimizu, S; Tahara, M; Tasaka, K | 1 |
Mills, GB; Murph, M | 1 |
8 review(s) available for lysophosphatidic acid and Disease Exacerbation
Article | Year |
---|---|
The Role of Lysophosphatidic Acid Receptors in Ovarian Cancer: A Minireview.
Topics: AMP-Activated Protein Kinases; Cell Transformation, Neoplastic; Chemokine CXCL1; Cyclin D1; Cyclooxygenase 2; Cytoskeletal Proteins; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Lysophospholipids; Ovarian Neoplasms; Peptide Fragments; Receptors, Lysophosphatidic Acid; Signal Transduction; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2020 |
The role of lipid signaling in the progression of malignant melanoma.
Topics: Animals; Arachidonic Acid; Cyclooxygenase 2; Disease Progression; Endocannabinoids; Genetic Predisposition to Disease; Humans; Lipid Metabolism; Lysophospholipids; Melanoma; Metabolic Networks and Pathways; Phosphatidylinositol 3-Kinases; Phospholipases; Phosphoric Diester Hydrolases; Prenylation; Prostaglandins; Receptors, Lysophosphatidic Acid; Signal Transduction | 2018 |
Roles of LPA in ovarian cancer development and progression.
Topics: Animals; Cell Transformation, Neoplastic; Disease Progression; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Signal Transduction | 2009 |
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
Topics: Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Disease Progression; Female; Humans; Lysophospholipids; Mice; Models, Biological; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Receptors, Lysophosphatidic Acid; Signal Transduction | 2010 |
Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Topics: Animals; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Male; Mice; Multienzyme Complexes; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phosphatidate Phosphatase; Phosphodiesterase I; Phospholipase D; Phosphoric Diester Hydrolases; Pyrophosphatases; Signal Transduction; Sphingosine | 2011 |
[Tubulo-interstitial fibrosis: an emerging major health problem].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Hypoxia; Chemokines; Cytokines; Disease Progression; Extracellular Matrix; Fibroblasts; Humans; Incidence; Intercellular Signaling Peptides and Proteins; Kallikrein-Kinin System; Kidney; Kidney Failure, Chronic; Lysophospholipids; Macrophages; Mice; Models, Biological; Morbidity; Myoblasts; Nephritis, Interstitial; Proteinuria; Renin-Angiotensin System | 2011 |
Platelets and metastasis revisited: a novel fatty link.
Topics: Blood Platelets; Bone and Bones; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Lysophospholipids; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Osteolysis; Ovarian Neoplasms | 2004 |
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.
Topics: Disease Progression; Drug Delivery Systems; Lysophospholipids; Neoplasms; Signal Transduction; Sphingosine; Treatment Outcome | 2007 |
1 trial(s) available for lysophosphatidic acid and Disease Exacerbation
Article | Year |
---|---|
Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis.
Topics: Biomarkers; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Lysophospholipids | 2023 |
20 other study(ies) available for lysophosphatidic acid and Disease Exacerbation
Article | Year |
---|---|
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; Disease Progression; Female; Humans; Logistic Models; Lysophospholipids; Male; Middle Aged; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Severity of Illness Index | 2021 |
LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Topics: Animals; Biomarkers, Tumor; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Humans; Immunohistochemistry; Lysophospholipids; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Ovarian Neoplasms; Receptors, Lysophosphatidic Acid; Signal Transduction | 2022 |
Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression.
Topics: Animals; Cell Line, Tumor; Cell Lineage; Cell Movement; Cell Proliferation; Disease Progression; Esophageal Squamous Cell Carcinoma; Heterografts; Humans; Lysophospholipids; Mice; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid | 2021 |
LPA
Topics: Animals; Cell Line, Tumor; Disease Progression; Eukaryotic Initiation Factor-2; Humans; Lymphangiogenesis; Lymphatic Metastasis; Lysophospholipids; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor C | 2018 |
Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.
Topics: Animals; Aortic Valve; Aortic Valve Stenosis; Apolipoprotein B-100; Blood Platelets; Calcinosis; Disease Progression; Humans; Integrin beta3; Lysophospholipids; Mice; Microscopy, Electron, Scanning; Osteogenesis; Phosphoric Diester Hydrolases; Platelet Membrane Glycoprotein IIb | 2019 |
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Disease Progression; Epidermal Growth Factor; Female; Humans; Lysophospholipids; Neoplasm Metastasis; Phenotype; Tumor Stem Cell Assay | 2013 |
Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.
Topics: Animals; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Group VI Phospholipases A2; Hydrogen Peroxide; Lysophospholipids; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Oligonucleotides, Antisense; Receptors, LDL; Signal Transduction; Stress, Physiological; Time Factors; Transfection; Up-Regulation | 2014 |
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cystadenocarcinoma, Serous; Disease Progression; Dose-Response Relationship, Drug; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphoproteins; RNA Interference; Signal Transduction; Transcription Factors; Transcription, Genetic; YAP-Signaling Proteins | 2015 |
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Extracellular Matrix; Heterografts; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction | 2016 |
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta | 2017 |
Lysophosphatidic acid signaling via LPA
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Cisplatin; Disease Progression; Drug Therapy, Combination; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2017 |
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.
Topics: Acyltransferases; Animals; Atherosclerosis; Carotid Arteries; Diet; Disease Progression; Gene Expression Profiling; Group VI Phospholipases A2; Homeostasis; Humans; Lysophospholipids; Male; Mice; Mice, Knockout; Molecular Sequence Data; Receptors, LDL | 2010 |
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
Topics: Actins; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fibroblasts; Humans; Liver Neoplasms; Lysophospholipids; Myofibroblasts; Phosphoric Diester Hydrolases | 2011 |
Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
Topics: Adherens Junctions; Caco-2 Cells; Cell Movement; Colonic Neoplasms; Disease Progression; Focal Adhesion Kinase 1; Focal Adhesions; Humans; Lysophospholipids; Phenotype; Protein Kinases; Proto-Oncogene Proteins pp60(c-src); rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Stress Fibers | 2011 |
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Topics: Antigens, CD; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits, G12-G13; Guanosine Triphosphate; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; Signal Transduction | 2011 |
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.
Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Cell Movement; Disease Progression; Endothelium, Vascular; Female; Kinetics; Lipids; Lysophospholipids; Male; Mice; Mice, Knockout; Monocytes; Platelet Activating Factor; Transplantation, Homologous | 2004 |
Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule.
Topics: Animals; Cattle; Chromatography, Thin Layer; Disease Progression; Dose-Response Relationship, Drug; Egg White; Lysophospholipids; Mass Spectrometry; Models, Chemical; Phosphates; Plant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Wound Healing; Zinc | 2004 |
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Topics: Animals; Blood Platelets; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cricetinae; Culture Media; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Doxycycline; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-6; Interleukin-8; Ki-67 Antigen; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogens; Models, Biological; Neoplasm Metastasis; Osteoclasts; Osteolysis; Phospholipase D; Platelet Activation; Platelet Aggregation; Reverse Transcriptase Polymerase Chain Reaction; RNA; Time Factors; Transfection | 2004 |
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Lysophospholipids; Mice; Neoplasm Metastasis; Osteoclasts; Propionates; Receptors, Lysophosphatidic Acid | 2006 |
Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Disease Progression; Diterpenes; Dose-Response Relationship, Drug; Female; Humans; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Phosphorylation; ras Proteins; Time Factors; Xenograft Model Antitumor Assays | 2007 |